In this study, we set out to explore the growth adaptation observed upon loss of ASCT2, expanding the HCC1806 data across four additional breast cancer cell lines, including both TNBC (glutamine addicted), Luminal A (glutamine independent) and HER2+ breast cancer cell lines. This evidence concerns the gene ERBB2 and breast carcinoma.